Building a GCT Platform for Mainstream Success - 2021 World Medical Innovation Forum
Virtual
May 19–21, 2021

Building a GCT Platform for Mainstream Success

Building a GCT Platform for Mainstream Success

Wednesday, May 19, 2021

9:50 AM – 10:15 AM

This panel of GCT executives, innovators and investors explore how to best shape a successful GCT strategy. Among the questions to be addressed:

  • How are GCT approaches set around defining and building a platform?
  • Is AAV the leading modality and what are the remaining challenges?
  • What are the alternatives?
  • Is it just a matter of matching modalities to the right indications?
Moderator:
Jean-François Formela, MD
  • Partner, Atlas Venture
Speakers:
Katherine High, MD
  • President, Therapeutics, AskBio
Dave Lennon, PhD
  • President, Novartis Gene Therapies
Rick Modi
  • CEO, Affinia Therapeutics
Louise Rodino-Klapac, PhD
  • EVP, Chief Scientific Officer, Sarepta Therapeutics
  • Q&A

    10:20 AM – 10:35 AM

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA